Radionuclide Reporter Imaging to Visualize Tumor Hypoxia Ex Vivo and In Vivo

Area of Science:

• Oncology
• Molecular Biology
• Medical Imaging

Background:

• In vitro models inadequately simulate intratumoral hypoxia, necessitating in vivo studies.
• Visible and near-infrared light imaging have limitations in tissue penetration and precise quantification for in vivo tumor hypoxia.
• Computed tomography (CT), radionuclide imaging, and magnetic resonance imaging (MRI) are ideal for in vivo quantitative analyses due to high tissue penetration.

Purpose of the Study:

• To develop and validate an advanced ex vivo and in vivo protocol for investigating the genetic response of hypoxia response elements (HREs) to tumor hypoxia.
• To precisely assess the intensity and intratumoral distribution of genetic responses to hypoxia using a human sodium/iodide symporter (hNIS) reporter gene.
• To utilize radionuclide reporter probes for accurate in vivo and ex vivo quantitative analyses of tumor hypoxia.

Main Methods:

• Cloning of an hNIS reporter construct containing multiple copies of HREs.
• Establishment of stable cell lines expressing the reporter construct.
• Preparation of a mouse subcutaneous xenograft model for in vivo studies.
• Evaluation of HREs' genetic response to tumor hypoxia using digital autoradiography (ARG) ex vivo and single-photon emission computed tomography (SPECT) or positron emission tomography (PET) in vivo.

Main Results:

• The protocol enables precise, quantitative assessment of tumor hypoxia's genetic impact in vivo.
• Radionuclide imaging (SPECT/PET) and autoradiography provide high-resolution data on HRE activity and distribution.
• The hNIS reporter system effectively visualizes and quantifies the genetic response to varying hypoxic conditions within tumors.

Conclusions:

• This protocol offers a robust method for studying tumor hypoxia and its genetic consequences in a clinically relevant manner.
• The combination of hNIS reporter gene and radionuclide imaging overcomes limitations of optical imaging for in vivo hypoxia research.
• The developed methods facilitate a deeper understanding of tumor biology and potential therapeutic strategies targeting hypoxia.